NASDAQ: GLMD
Galmed Pharmaceuticals Ltd Stock Ownership - Who owns Galmed Pharmaceuticals?

Insider buying vs selling

Have Galmed Pharmaceuticals Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when GLMD insiders and whales buy or sell their stock.

GLMD Shareholders

What type of owners hold Galmed Pharmaceuticals Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Schonfeld Strategic Advisors LLC1.54%25,400$35.05kInstitution
Morgan Stanley0.76%12,530$17.29kInstitution
Ubs Group Ag0.41%6,721$9.27kInstitution
Tower Research Capital LLC Trc0.00%59$81.42Institution
Wells Fargo Company0.00%18$24.84Institution
Tsfg LLC0.00%17$23.46Institution
Sbi Securities Co Ltd0.00%16$22.08Institution
Federation Des Caisses Desjardins Du Quebec0.00%14$19.32Institution
Osaic Holdings Inc0.00%5$6.90Institution
Allworth Financial LP0.00%2$2.76Institution

1 of 2

GLMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GLMD2.71%0.00%
ENSC3.21%96.79%
THAR3.64%96.36%Net Buying
ONVO12.44%87.56%
KZIA0.48%33.42%

Galmed Pharmaceuticals Stock Ownership FAQ

Who owns Galmed Pharmaceuticals?

Galmed Pharmaceuticals (NASDAQ: GLMD) is owned by 2.71% institutional shareholders, 0.00% Galmed Pharmaceuticals insiders, and 97.29% retail investors. Schonfeld Strategic Advisors LLC is the largest individual Galmed Pharmaceuticals shareholder, owning 25,400.00 shares representing 1.54% of the company. Schonfeld Strategic Advisors LLC's Galmed Pharmaceuticals shares are currently valued at $35.56k.

If you're new to stock investing, here's how to buy Galmed Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.